These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 24260282)

  • 21. Hormone replacement therapy containing progestins and given continuously increases breast carcinoma risk in Sweden.
    Olsson HL; Ingvar C; Bladström A
    Cancer; 2003 Mar; 97(6):1387-92. PubMed ID: 12627501
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hormone replacement therapy use and variations in the risk of breast cancer.
    Opatrny L; Dell'Aniello S; Assouline S; Suissa S
    BJOG; 2008 Jan; 115(2):169-75; discussion 175. PubMed ID: 18081598
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Postmenopausal estrogen-containing hormone therapy and the risk of breast cancer.
    Jick SS; Hagberg KW; Kaye JA; Jick H
    Obstet Gynecol; 2009 Jan; 113(1):74-80. PubMed ID: 19104362
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A prospective study of different types of hormone replacement therapy use and the risk of subsequent breast cancer: the women's health in the Lund area (WHILA) study (Sweden).
    Jernström H; Bendahl PO; Lidfeldt J; Nerbrand C; Agardh CD; Samsioe G
    Cancer Causes Control; 2003 Sep; 14(7):673-80. PubMed ID: 14575365
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Breast cancer risk with postmenopausal hormonal treatment.
    Collins JA; Blake JM; Crosignani PG
    Hum Reprod Update; 2005; 11(6):545-60. PubMed ID: 16150813
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Menopause hormone replacement therapy and cancer risk: an Italian record linkage investigation.
    Corrao G; Zambon A; Conti V; Nicotra F; La Vecchia C; Fornari C; Cesana G; Contiero P; Tagliabue G; Nappi RE; Merlino L
    Ann Oncol; 2008 Jan; 19(1):150-5. PubMed ID: 17785762
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Breast-cancer risk following long-term oestrogen- and oestrogen-progestin-replacement therapy.
    Magnusson C; Baron JA; Correia N; Bergström R; Adami HO; Persson I
    Int J Cancer; 1999 May; 81(3):339-44. PubMed ID: 10209946
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hormone replacement therapy and cancer.
    Gynecol Endocrinol; 2001 Dec; 15(6):453-65. PubMed ID: 11826770
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hormone replacement therapy and the risk of breast cancer.
    Narod SA
    Nat Rev Clin Oncol; 2011 Aug; 8(11):669-76. PubMed ID: 21808267
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Breast Cancer Incidence and Mortality in Relation to Hormone Replacement Therapy Use Among Postmenopausal Women: Results From a Prospective Cohort Study.
    Jiang Y; Xie Q; Chen R
    Clin Breast Cancer; 2022 Feb; 22(2):e206-e213. PubMed ID: 34548240
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hormone replacement therapy and cancer risks in perimenopausal women: A retrospective cohort study using a Japanese claims database.
    Inayama Y; Mizuno K; Yamaguchi K; Hamanishi J; Takeuchi M; Egawa M; Mandai M; Kawakami K
    J Obstet Gynaecol Res; 2023 Jul; 49(7):1805-1814. PubMed ID: 37029559
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Breast cancer risk in relation to different types of hormone replacement therapy in the E3N-EPIC cohort.
    Fournier A; Berrino F; Riboli E; Avenel V; Clavel-Chapelon F
    Int J Cancer; 2005 Apr; 114(3):448-54. PubMed ID: 15551359
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Hormone replacement therapy in menopause and risk of breast cancer].
    Clavel-Chapelon F; Hill C
    Presse Med; 2000 Oct; 29(31):1688-93. PubMed ID: 11094609
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term hormone replacement therapy and risk of breast cancer in postmenopausal women.
    Newcomb PA; Longnecker MP; Storer BE; Mittendorf R; Baron J; Clapp RW; Bogdan G; Willett WC
    Am J Epidemiol; 1995 Oct; 142(8):788-95. PubMed ID: 7572954
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Relationship between the type of hormone replacement therapy and incidence of breast cancer in Korea.
    Baek JK; Kim HI; Kang MJ; Seon KE; Kim EH; Seo SK
    Climacteric; 2022 Oct; 25(5):516-522. PubMed ID: 35674251
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Does the type of hormone replacement therapy influence the risk of deep vein thrombosis? A prospective case-control study.
    Douketis JD; Julian JA; Kearon C; Anderson DR; Crowther MA; Bates SM; Barone M; Piovella F; Turpie AG; Middeldorp S; van Nguyen P; Prandoni P; Wells PS; Kovacs MJ; MacGillavry MR; Costantini L; Ginsberg JS
    J Thromb Haemost; 2005 May; 3(5):943-8. PubMed ID: 15869589
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genetic polymorphisms in phase I and phase II enzymes and breast cancer risk associated with menopausal hormone therapy in postmenopausal women.
    MARIE-GENICA Consortium on Genetic Susceptibility for Menopausal Hormone Therapy Related Breast Cancer Risk
    Breast Cancer Res Treat; 2010 Jan; 119(2):463-74. PubMed ID: 19424794
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cancer risk in women receiving estrogen-progestin replacement therapy.
    Persson I
    Maturitas; 1996 May; 23 Suppl():S37-45. PubMed ID: 8865138
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Progestins and breast cancer.
    Eden J
    Am J Obstet Gynecol; 2003 May; 188(5):1123-31. PubMed ID: 12748456
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Menopausal hormone therapy and breast cancer risk: a population-based cohort study of 1.3 million women in Norway.
    Støer NC; Vangen S; Singh D; Fortner RT; Hofvind S; Ursin G; Botteri E
    Br J Cancer; 2024 Jul; 131(1):126-137. PubMed ID: 38740969
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.